80054991 - Update on Melanoma and Non-Melanoma Skin Cancer


Update on Melanoma and Non-Melanoma Skin Cancer Banner

Add to Calendar Update on Melanoma and Non-Melanoma Skin Cancer 5/13/2021 6:00:00 PM 5/13/2021 10:00:00 PM America/New_York For More Details: https://hopkinscme.cloud-cme.com/course/courseoverview?EID=32226 Description: In the United States, the incidence of skin cancer is greater than that of all other cancers combined. Early diagnosis of melanoma and other aggressive skin cancers can be lifesaving. In recent years, new immunotherapies and targeted therapies have achieved positive results in many patients with advanced melanoma. This activity aims to update physicians with new information on diagnosis and treatm... Zoom Meeting false MM/DD/YYYY


Date & Location
Thursday, May 13, 2021, 6:00 PM - 10:00 PM, Zoom Meeting

Target Audience
Specialties - Dermatology, Family Practice, General Practice, General Surgery, Internal Medicine, Nurse Practitioner, Nursing, Oncology, Physician Assistant, Public Health

Overview
In the United States, the incidence of skin cancer is greater than that of all other cancers combined. Early diagnosis of melanoma and other aggressive skin cancers can be lifesaving. In recent years, new immunotherapies and targeted therapies have achieved positive results in many patients with advanced melanoma. This activity aims to update physicians with new information on diagnosis and treatment of melanoma andnon-melanoma skin cancer. This activity will consist of a series of brief lectures and case presentations virtually.

Who Should Attend
This activity is intended for dermatologists, internists, family physicians, surgeons, plastic surgeons, dermatologic surgeons, medical oncologists, radiation oncologists, oncology nurses, and physician assistants

FEE
Registration Fee: $35

Objectives
  1. Identify challenges in interpreting melanoma pathology.
  2. Recognize controversies regarding the surgery of melanoma patients.
  3. Discuss the newly approved therapies for high risk and advanced melanoma.
  4. Discuss how to integrate old and new melanoma therapies.
  5. Identify new therapies in clinical trials for melanoma.
  6. Explain the initial treatment and the use of the gene signature in ocular melanoma.

Accreditation
Accreditation Statement
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement
The Johns Hopkins University School of Medicine designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Keywords: LIVE